Alopecia areata: A condition caused by an overactive immune system attacking hair follicles.There is a genetic component to this condition, but more research is needed. Androgenetic alopecia (male ...

Yes, so alopecia areata most commonly is characterized by a spot or a few spots of hair loss. And these can be the size of a nickel. These could be the size of a half-dollar.

Design. The two randomized, placebo-controlled, phase 3 studies BRAVE-AA1 and BRAVE-AA2 included 654 adult patients. The average age was about 38 years, and women accounted for 60% of the population.

Trials of the first drug to treat alopecia areata showed strong results, with 30 to 40% of participants able to regrow nearly all of their hair. By. Julie Mazziotta. Julie Mazziotta.

Congresswoman Ayanna Pressley reveals she has alopecia 01:40. The Food and Drug Administration on Monday approved a drug called baricitinib as the first for treating severe alopecia areata, an ...

Equillium announced positive topline data from its phase 2, single-dose, proof-of-concept study of EQ101 for the treatment of adults with moderate, severe or very severe alopecia areata, according ...

But living with alopecia areata doesn’t mean you have to accept facial hair loss if you’re not comfortable with it. Several cosmetic procedures are available to help address AA and conceal the ...

The study saw 158 participants with mild or moderate alopecia areata receive one of four doses of STS-01—ranging from 0.25% to 2%—or placebo applied over 24 weeks.

A medicine for severe hair loss, or alopecia, is being recommended on the NHS for the first time. The daily pill, called ritlecitinib or Litfulo, could help up to 14,000 people in England, says ...